Patents by Inventor Ryan Cirz

Ryan Cirz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11414450
    Abstract: Provided herein are aminoglycoside compounds, such as compounds of formula (I), (II), (III), (IV), (IVa), (V), (VI), (VIIa), or (VIIb) or pharmaceutically acceptable salts, solvates, stereoisomers, or tautomers of any of the foregoing, useful as therapeutic or prophylactic agents. Also provided herein are methods for their preparation. The compounds may be useful in treating a bacterial infection in a subject, for example a Gram-negative bacterial infection.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: August 16, 2022
    Assignee: REVAGENIX, INC.
    Inventors: Logan Andrews, Andrew Calabrese, Timothy Robert Kane, Ryan Cirz, Frederick Cohen, Michael Lopez, John Knox, Nikolai Evdokimov
  • Patent number: 10624899
    Abstract: Provided herein are methods of treating a bacterial infection, wherein the methods comprise administering (a) ceftibuten or a pharmaceutically acceptable salt thereof, or a hydrate of the foregoing; and (b) clavulanic acid, or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions, articles of manufacture, and kits comprising a) ceftibuten or a pharmaceutically acceptable salt thereof, or a hydrate of the foregoing; and (b) clavulanic acid, or a pharmaceutically acceptable salt thereof, and uses thereof.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: April 21, 2020
    Assignee: ACHAOGEN, INC.
    Inventors: Kevin Michael Krause, Daniel John Cloutier, Allison Seiko Komirenko, Ian Friedland, Ryan Cirz, Adrian Jubb, Logan Andrews
  • Publication number: 20190031743
    Abstract: Provided are assays or methods for identifying antibodies that bind to microorganisms, e.g., pathogenic microorganisms, such as bacteria other infectious agents. In some embodiments, the provided methods for identifying an antibody that binds the target microorganism involves gel encapsulation of antibody-producing cells in gel microdroplets with a target microorganism. Also provided are antibodies produced by the method. Also provided are antibodies that bind a conserved region or epitope across variants or species of Acenitobacter.
    Type: Application
    Filed: January 27, 2017
    Publication date: January 31, 2019
    Inventors: Lee Robert SWEM, Ryan CIRZ, Monica SCHWARTZ, Kristina BENDER, Shuang WU, Felix FINDEISEN, Malavika KANNUSWAMY, Dante RICCI, Ami PATEL
  • Publication number: 20180015100
    Abstract: Provided herein are methods of treating a bacterial infection, wherein the methods comprise administering (a) ceftibuten or a pharmaceutically acceptable salt thereof, or a hydrate of the foregoing; and (b) clavulanic acid, or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions, articles of manufacture, and kits comprising a) ceftibuten or a pharmaceutically acceptable salt thereof, or a hydrate of the foregoing; and (b) clavulanic acid, or a pharmaceutically acceptable salt thereof, and uses thereof.
    Type: Application
    Filed: July 13, 2017
    Publication date: January 18, 2018
    Applicant: ACHAOGEN, INC.
    Inventors: Kevin Michael KRAUSE, Daniel John CLOUTIER, Allison Seiko KOMIRENKO, Ian FRIEDLAND, Ryan CIRZ, Adrian JUBB, Logan ANDREWS
  • Publication number: 20090136518
    Abstract: The present invention provides methods and compositions for said inhibition of drug resistance. In one embodiment, said invention provides methods and compositions for said inhibition of antibiotic resistance. The invention generally involves said administration of achaogens, agents that inhibit said mutational process, to inhibit said evolution of drug resistance. Also, described herein are compositions that are suitable for use as achaogens.
    Type: Application
    Filed: October 9, 2008
    Publication date: May 28, 2009
    Applicants: The Scripps Research Institute, Achaogen, Inc.
    Inventors: Floyd Romesberg, Nathaniel E. David, Ryan Cirz
  • Patent number: 7455840
    Abstract: The present invention provides methods and compositions for said inhibition of drug resistance. In one embodiment, said invention provides methods and compositions for said inhibition of antibiotic resistance. The invention generally involves said administration of achaogens, agents that inhibit said mutational process, to inhibit said evolution of drug resistance. Also, described herein are compositions that are suitable for use as achaogens.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: November 25, 2008
    Assignees: The Scripps Research Institute, Achaogen, Inc.
    Inventors: Floyd Romesberg, Nathaniel E. David, Ryan Cirz
  • Publication number: 20060286574
    Abstract: The present invention provides compositions useful in treating drug-resistant microorganisms and cells, as well as related methods of identifying and using such compositions. In addition, the present invention includes compositions useful in enhancing the sensitivity of both drug-resistant and drug-sensitive microorganisms and cells to microbicidal and cytotoxic agents, including antibiotics and chemotherapeutic drugs. Methods of identifying these compositions, as well as methods of using these agents in treating both drug-resistant and drug-sensitive diseases and conditions are further provided.
    Type: Application
    Filed: April 5, 2006
    Publication date: December 21, 2006
    Applicants: The Scripps Research Institute & Achaogen, Inc., Achaogen Inc.
    Inventors: Floyd Romesberg, Ryan Cirz, Philip Patten
  • Publication number: 20060111302
    Abstract: The present invention provides methods and compositions for said inhibition of drug resistance. In one embodiment, said invention provides methods and compositions for said inhibition of antibiotic resistance. The invention generally involves said administration of achaogens, agents that inhibit said mutational process, to inhibit said evolution of drug resistance. Also, described herein are compositions that are suitable for use as achaogens.
    Type: Application
    Filed: November 19, 2004
    Publication date: May 25, 2006
    Inventors: Floyd Romesberg, Nathaniel David, Ryan Cirz